[Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation]. 1985

L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini

UI MeSH Term Description Entries
D008297 Male Males
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D003846 Deoxyepinephrine Sympathomimetic, vasoconstrictor agent. Deoxyadrenaline,Desoxyadrenaline,Methyldopamine,Desoxyepinephrine,Epinine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005292 Ferricyanides Inorganic salts of the hypothetical acid, H3Fe(CN)6.
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
August 1985, Clinical cardiology,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
January 1990, Cardiology,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
July 1983, Kardiologiia,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
January 1986, Pharmacotherapy,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
May 1991, The American journal of medicine,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
January 1983, Journal of cardiovascular pharmacology,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
February 1986, Arzneimittel-Forschung,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
January 1986, Journal of cardiovascular pharmacology,
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
January 1982, Cardiologia (Rome, Italy),
L Dei Cas, and G Giunti, and P Faggiano, and A Fappani, and R Ferrari, and G La Canna, and S Riva, and R Zanini
March 1995, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!